Pacific Biosciences Of California Total Assets 2010-2024 | PACB

Pacific Biosciences Of California total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Pacific Biosciences Of California Annual Total Assets
(Millions of US $)
2023 $1,746
2022 $1,767
2021 $2,007
2020 $414
2019 $148
2018 $170
2017 $144
2016 $138
2015 $131
2014 $124
2013 $136
2012 $130
2011 $218
2010 $306
2009 $101
Pacific Biosciences Of California Quarterly Total Assets
(Millions of US $)
2024-03-31 $1,670
2023-12-31 $1,746
2023-09-30 $1,898
2023-06-30 $1,848
2023-03-31 $1,896
2022-12-31 $1,767
2022-09-30 $1,819
2022-06-30 $1,876
2022-03-31 $1,937
2021-12-31 $2,007
2021-09-30 $2,034
2021-06-30 $1,246
2021-03-31 $1,253
2020-12-31 $414
2020-09-30 $300
2020-06-30 $214
2020-03-31 $235
2019-12-31 $148
2019-09-30 $146
2019-06-30 $171
2019-03-31 $186
2018-12-31 $170
2018-09-30 $183
2018-06-30 $137
2018-03-31 $157
2017-12-31 $144
2017-09-30 $158
2017-06-30 $178
2017-03-31 $136
2016-12-31 $138
2016-09-30 $151
2016-06-30 $161
2016-03-31 $140
2015-12-31 $131
2015-09-30 $100
2015-06-30 $97
2015-03-31 $106
2014-12-31 $124
2014-09-30 $122
2014-06-30 $128
2014-03-31 $141
2013-12-31 $136
2013-09-30 $153
2013-06-30 $134
2013-03-31 $140
2012-12-31 $130
2012-09-30 $148
2012-06-30 $170
2012-03-31 $195
2011-12-31 $218
2011-09-30 $238
2011-06-30 $261
2011-03-31 $279
2010-12-31 $306
2010-09-30 $130
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.523B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.743B 27.48
Intuitive Surgical (ISRG) United States $141.891B 85.48
Edwards Lifesciences (EW) United States $54.101B 35.21
DexCom (DXCM) United States $51.973B 78.73
IDEXX Laboratories (IDXX) United States $43.777B 51.31
Alcon (ALC) Switzerland $43.442B 31.13
IQVIA Holdings (IQV) United States $41.922B 24.32
STERIS (STE) Ireland $22.999B 26.88
Waters (WAT) United States $21.000B 30.86
SONOVA HOLDING (SONVY) Switzerland $18.908B 0.00
Hologic (HOLX) United States $17.468B 19.54
Fresenius Medical Care AG KGaA (FMS) Germany $12.869B 15.02
ShockWave Medical (SWAV) United States $12.384B 77.07
Sysmex ADR (SSMXY) Japan $11.134B 34.91
Teleflex (TFX) United States $10.108B 15.73
Globus Medical (GMED) United States $8.970B 26.29
Penumbra (PEN) United States $7.809B 88.74
Masimo (MASI) United States $6.723B 38.73
Glaukos (GKOS) United States $5.504B 0.00
TransMedics (TMDX) United States $4.566B 433.19
Integer Holdings (ITGR) United States $4.029B 24.34
PROCEPT BioRobotics (PRCT) United States $3.533B 0.00
LivaNova (LIVN) United Kingdom $3.318B 19.70
Tandem Diabetes Care (TNDM) United States $3.051B 0.00
Elekta AB (EKTAY) Sweden $2.973B 20.40
Inari Medical (NARI) United States $2.682B 0.00
Nihon Kohden (NHNKY) Japan $2.474B 20.92
RxSight (RXST) United States $2.317B 0.00
Integra LifeSciences Holdings (IART) United States $2.126B 9.27
Veracyte (VCYT) United States $1.705B 0.00
Alphatec Holdings (ATEC) United States $1.543B 0.00
Artivion (AORT) United States $0.993B 95.24
AVANOS MEDICAL, INC (AVNS) United States $0.933B 18.14
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.897B 0.00
OrthoPediatrics (KIDS) United States $0.775B 0.00
Mesa Laboratories (MLAB) United States $0.656B 22.26
Paragon 28 (FNA) United States $0.621B 0.00
SiBone (SIBN) United States $0.593B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.567B 0.00
IRadimed (IRMD) United States $0.555B 31.07
Pulse Biosciences (PLSE) United States $0.474B 0.00
Nevro (NVRO) United States $0.386B 0.00
Tactile Systems Technology (TCMD) United States $0.324B 11.10
Treace Medical Concepts (TMCI) United States $0.306B 0.00
Sight Sciences (SGHT) United States $0.282B 0.00
AxoGen (AXGN) United States $0.271B 0.00
908 Devices (MASS) United States $0.236B 0.00
AngioDynamics (ANGO) United States $0.233B 0.00
EDAP TMS S.A (EDAP) France $0.231B 0.00
NeuroPace (NPCE) United States $0.230B 0.00
Delcath Systems (DCTH) United States $0.223B 0.00
Inogen (INGN) United States $0.207B 0.00
Atossa Genetics (ATOS) United States $0.201B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.179B 0.00
ClearPoint Neuro (CLPT) United States $0.168B 0.00
Semler Scientific (SMLR) United States $0.166B 8.42
Accuray (ARAY) United States $0.159B 0.00
Spectral Diagnostics (EDTXF) Canada $0.108B 0.00
Sensus Healthcare (SRTS) United States $0.103B 21.59
KORU Medical Systems (KRMD) United States $0.101B 0.00
Yubo Biotech (YBGJ) China $0.091B 0.00
Neuronetics (STIM) United States $0.076B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Envoy Medical (COCH) United States $0.064B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
Vicarious Surgical (RBOT) United States $0.056B 0.00
SEP Acquisition (SEPA) United States $0.054B 0.00
DarioHealth (DRIO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.046B 0.00
Autonomix Medical (AMIX) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
T2 Biosystems (TTOO) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Aspira Women's Health (AWH) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00